Navigation Links
Siemens MAGNETOM Spectra 3T MRI System Receives FDA Clearance

MALVERN, Pa., July 24, 2012 /PRNewswire/ -- Siemens Healthcare (NYSE: SI) has announced that the MAGNETOM Spectra 3 Tesla MRI system has received clearance from the U.S. Food and Drug Administration (FDA). The latest addition to Siemens' internationally renowned portfolio of MRI solutions, the MAGNETOM Spectra system offers premium imaging at a reduced total cost of ownership compared to other scanners in this product range, providing hospitals and radiological institutes with easier access to the highly coveted 3T technology, which yields excellent image quality and rapid scan times. Designed for easy and efficient operation, the cost-optimized MAGNETOM Spectra system is innovative and competitive – two primary goals of the Healthcare Sector's Agenda 2013 two-year global initiative.


"Siemens Healthcare is proud to offer the MAGNETOM Spectra MRI system, which opens the door to 3T imaging technology for a wider range of health care facilities than ever before," said Ioannis Panagiotelis, PhD, vice president of MR, Siemens Healthcare. "The MAGNETOM Spectra delivers crisp, high-resolution images that provide the key to a new level of usability and diagnostic confidence for physicians."

The MAGNETOM Spectra system employs Tim (Total imaging matrix) 4G technology – Siemens' latest coil generation that unlocks a new level of imaging accuracy and flexibility. This modern array structure allows for high spatial and temporal resolution, which, along with a high-quality signal-to-noise ratio, enables Tim 4G to deliver outstanding image quality. Until now, images of similar quality could be produced only by high-end 3T systems, which require a higher investment. The MAGNETOM Spectra enables private radiology practices, imaging centers and clinics to benefit from high imaging quality for their clinical routine.

The MAGNETOM Spectra system also consumes less energy than other 3T scanners. Furthermore, the magnet-cooling helium is contained in a closed loop, preventing the gas from escaping and reducing the need for costly refills. In addition, various components of the MAGNETOM Spectra help technologists simplify the MRI examination process. For example, the cableless direct-connect coils allow for simple and quick setup, with up to 120 coil elements capable of being combined in a flexible manner. For this reason, even large scans with large anatomical coverage up to whole-body scans (205 cm, or 80.71 inches) can be performed in one examination without patient or coil repositioning.

The MAGNETOM Spectra system can be used for a broad spectrum of applications, from diagnosing damaged ankle cartilage to conducting dynamic abdominal examinations to performing functional brain imaging. To reduce exam complexity, the MAGNETOM Spectra is equipped with Siemens' MRI workflow solution Dot (Day optimizing throughput), which enables easy, fast selection of the best scan strategy based on the patient's condition and the clinical indication. Users benefit from step-by-step guidance throughout the examination, receiving decision-making assistance at critical junctures to support consistent, reproducible scanning across patients. Thanks to Siemens' Tim and Dot technologies, high-quality images can be produced in less time.

Launched by Siemens Healthcare Sector, Agenda 2013 is a two-year global initiative to further strengthen the Healthcare Sector's innovative power and competitiveness. Specific measures will be implemented in four fields of action: Innovation, Competitiveness, Regional Footprint, and People Development.

The Siemens Healthcare Sector is one of the world's largest suppliers to the healthcare industry and a trendsetter in medical imaging, laboratory diagnostics, medical information technology and hearing aids. Siemens offers its customers products and solutions for the entire range of patient care from a single source – from prevention and early detection to diagnosis, and on to treatment and aftercare. By optimizing clinical workflows for the most common diseases, Siemens also makes healthcare faster, better and more cost-effective. Siemens Healthcare employs some 51,000 employees worldwide and operates around the world. In fiscal year 2011 (to September 30), the Sector posted revenue of 12.5 billion euros and profit of around 1.3 billion euros. For further information please visit:


SOURCE Siemens Healthcare
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Sysmex and Siemens Renew Global Partnership for Hemostasis Solutions and Services
2. Siemens Launches Next Generation Automation Solution Aptio at AACC 2012
3. Siemens Unveils New Solutions and Latest Innovations at AACC 2012
4. Frost & Sullivan Recognizes Siemens Healthcares CT Imaging Solution for the Value it Offers Both Service Providers and Patients
5. Siemens SOMATOM Definition Edge Single-Source CT Cleared for Sale in U.S.
6. FDA Clears New Siemens SOMATOM Perspective CT Scanner
7. At SIIM 2012 Siemens Healthcare Demonstrates Departmental IT Solutions That Help Administrators Increase Access while Managing Costs
8. Varian Medical Systems and Siemens Healthcare Announce Global Collaboration to Advance Clinical Capabilities and Offerings in Radiotherapy and Radiosurgery
9. Global Central Nervous System Drugs Market 2011-2015
10. Lifeline Biotechnologies First Warning Systems
11. FDA clears Accu-Chek Combo system - Roches new interactive insulin pump system for people with diabetes
Post Your Comments:
(Date:11/24/2015)... The hope of bearing a ... IVF cycles. After failure of over 15 IVF cycles, ... all hopes that she would be able to conceive ever. But finally optimism prevailed as ... failure of over 15 IVF cycles. ... take one last attempt with Gaudium IVF Center in ...
(Date:11/24/2015)... CARLOS, Calif. , Nov. 24, 2015 ... a leader in non-invasive genetic testing and ... announced that it will present at the ... in New York on Wednesday, December 2, 2015 at 1:00 p.m. ET.  Matthew ... the Company,s financial results, business activities and ...
(Date:11/24/2015)... 2015 /PRNewswire/ - ESSA Pharma Inc. ("ESSA" or the ... that the first patient has been enrolled in ESSA,s ... for metastatic castration-resistant prostate cancer ("mCRPC"). ... --> the United States and ... clinical trial, ESSA intends to demonstrate the safety, tolerability, ...
Breaking Medicine Technology:
(Date:11/24/2015)... ... November 24, 2015 , ... Brillouin Energy ... Brillouin is the developer of renewable energy technologies capable of producing commercially useful ... announced today that its WET™ and HHT™ Boiler System reactor core modules were ...
(Date:11/24/2015)... , ... November 24, 2015 , ... ... the United States to support their local poison centers through donations on Tuesday, ... #GivingTuesday: calls it “a day that inspires people to collaborate in improving ...
(Date:11/24/2015)... ... , ... Aided by seed funding from the Ron Foley Foundation, researchers at ... into how to detect and treat pancreatic cancer (PC). , WCHN researchers will ... molecules (ncRNA), genetic material that is present in the blood of patients with PC. ...
(Date:11/24/2015)... ... ... Willey , has answered a new calling – to relieve snoring and sleep apnea for ... and sleep apnea through oral appliance therapy. He is one of a number ... of four in the Illinois area. , Dr. Willey’s location is at 11825 ...
(Date:11/24/2015)... ... , ... Autism Speaks, the world’s leading autism science and advocacy organization, will ... generosity of people around the world. On December 1, supporters can make an online ... share the personal stories behind those gifts. , Just as Black Friday and ...
Breaking Medicine News(10 mins):